L. Kaplan

CALGB 150905 (Alliance): Rituximab Broadens the Antilymphoma Response by Activating Unlicensed NK Cells

M. Czuczman, B. Cheson, Sin-Ho Jung, 2014, Cancer Immunology Research.

Romidepsin Plus Liposomal Doxorubicin Is Safe and Effective in Patients with Relapsed or Refractory T-Cell Lymphoma: Results of a Phase I Dose-Escalation Study

F. McCormick, P. Porcu, C. Andreadis, 2019, Clinical Cancer Research.

Response by Activating Unlicensed NK Cells CALGB 150905 (Alliance): Rituximab Broadens the Antilymphoma

M. Czuczman, B. Cheson, B. Pitcher, 2014 .

Combination Therapy with Zidovudine and Didanosine Compared with Zidovudine Alone in HIV-1 Infection

P. Volberding, A. Collier, L. Corey, 1993, Annals of Internal Medicine.

Left ventricular rupture due to HIV-associated T-cell lymphoma.

E. Armstrong, P. Ursell, Y. Yeghiazarians, 2010, Texas Heart Institute Journal.

Hypoxia-specific imaging in patients with lymphoma undergoing CAR-T therapy.

V. Wang, Chiung-Yu Huang, C. Andreadis, 2023, European journal of nuclear medicine and molecular imaging.

Evaluation of pulmonary toxicities in lymphoma patients receiving brentuximab vedotin

C. Andreadis, W. Ai, B. Fakhri, 2021, Leukemia & lymphoma.